SCHEMBL17224635

SCHEMBL17224635

O=C(c1cc(F)cc(F)c1)c1c[nH]nc1-c1cc(Cl)cc(Cl)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 7/20 0.33
CNR2 P34972 6/20 0.33
CCNB2 O95067 2/20 0.33
CCNE2 O96020 2/20 0.33
CDK1 P06493 2/20 0.33
CDK4 P11802 2/20 0.33
CCNB1 P14635 2/20 0.33
CCND1 P24385 2/20 0.33
CCNE1 P24864 2/20 0.33
CDK2 P24941 2/20 0.33
CCND2 P30279 2/20 0.33
CCND3 P30281 2/20 0.33
CCNB3 Q8WWL7 2/20 0.33
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HTT P42858 1/20 0.33
RXRA P19793 1/20 0.31
RXRB P28702 1/20 0.31
XPO1 O14980 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17224658 0.90 CES2 (0.38) CNR1CNR2CCNB2CCNE2CDK1
SCHEMBL17224633 0.87 CES2 (0.40) CNR1CNR2CES2CES1ALDH1A1
SCHEMBL17224655 0.85 CES2 (0.38) CES2CES1ALDH1A1HTTNPC1
SCHEMBL17224621 0.83 CES2 (0.41) CCNB2CCNE2CDK1CDK4CCNB1
SCHEMBL17338472 0.82 CNR2 (0.49) CNR1CNR2CCNB2CCNE2CDK1
SCHEMBL17224620 0.81 CES2 (0.41) CCNB2CCNE2CDK1CDK4CCNB1
SCHEMBL17224660 0.78 CCNB2 (0.42) CCNB2CCNE2CDK1CDK4CCNB1
SCHEMBL23294328 0.77 KMO (0.42) CNR1ALDH1A1RXRARXRBSMN1; SMN2
SCHEMBL17224662 0.75 CES2 (0.44) CCNB2CCNE2CDK1CDK4CCNB1
SCHEMBL8182394 0.71 RORB (0.46) CNR1CNR2CCNE2CCNE1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9926278-B2 Sulfonyl hydrazide compounds and a regio-selective process to prepare 4-aroyl pyrazole derivatives E. I. DU PONT DE NEMOURS AND COMPANY (US) 2018-03-27 US disclosed
US-20170044109-A1 SULFONYL HYDRAZIDE COMPOUNDS AND A REGIO-SELECTIVE PROCESS TO PREPARE 4-AROYL PYRAZOLE DERIVATIVES FMC CORPORATION 2017-02-16 US disclosed
WO-2015167795-A1 HERBICIDAL SUBSTITUTED 3-PHENYL-4-FLUOROBENZOYL PYRAZOLES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2015-11-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170044109-A1 SULFONYL HYDRAZIDE COMPOUNDS AND A REGIO-SELECTIVE PROCESS TO PREPARE 4-AROYL PYRAZOLE DERIVATIVES ALDH3A1, SQOR, ADORA3 CNR1 625/4885CNR2 611/4885CCNB2 2904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.